Evaluation of living liver donors identifying as transgender or gender diverse

Liver Transpl. 2026 Apr 1;32(4):620-626. doi: 10.1097/LVT.0000000000000712. Epub 2025 Aug 22.

Abstract

Transgender and gender diverse individuals face barriers to accessing equitable healthcare. As the liver transplant community works to expand and standardize the living donor evaluation, it is imperative that we consider the unique risk stratification considerations for this marginalized population. Herein, we review the nuances unique to psychosocial and medical considerations, including gender-affirming hormone therapy and perioperative management, with a focus on creating an inclusive environment.

Keywords: gender affirming hormone therapy; living donor liver transplantation; transgender liver donor.

Publication types

  • Review

MeSH terms

  • Donor Selection* / methods
  • Donor Selection* / standards
  • Female
  • Health Services Accessibility
  • Hepatectomy* / adverse effects
  • Humans
  • Liver Transplantation* / adverse effects
  • Liver Transplantation* / methods
  • Living Donors* / psychology
  • Male
  • Risk Assessment
  • Transgender Persons* / psychology